This page follows insider dealings at Medassets Inc as filed with SEC (Form 4). Medassets Inc has had no insider filing for more than a year; the last one goes back to 27 January 2016.
Other companies in the same market with recent insider buying flagged by our signals: Relmada Therapeutics, Inc. and Uber Technologies, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
FY ended December 2014 · cache
25 of 95 declarations
Medassets Inc is a company that specializes in cost and revenue management solutions for the healthcare sector. It provides tools to enhance the financial efficiency of healthcare organizations.
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2014 | n.d. | -20.4 m USD | -0.34 USD | 10-K |
| Dec 2013 | n.d. | 27.4 m USD | 0.45 USD | 10-K |
| Dec 2012 | n.d. | -6.9 m USD | -0.12 USD | 10-K |
| Dec 2011 | n.d. | -15.5 m USD | -0.27 USD | 10-K |
| Dec 2010 | n.d. | -32.1 m USD | -0.57 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.